"The development of our KUBio modular manufacturing facilities and FlexFactory single-use manufacturing platform was fuelled by the need for customers to deploy biopharmaceutical manufacturing capacity more quickly and at a lower cost. Implementing these advanced technology platforms requires automation expertise for which we partner with a number of world-class companies. With Zenith Technologies' expertise in automation integration and customer support, we will be able to offer more choice to customers."

Kevin A Lobo
Chairman and Chief Executive Officer,

Stryker Corporation has entered into a definitive agreement to acquire 100 percent of the stock of Physio-Control International, Inc. in an all-cash transaction for USD 1.28 billion. Physio-Control, which is a portfolio company of Bain Capital Private Equity, develops, manufactures, and markets monitors/defibrillators, automated external defibrillators (AEDs), and CPR-assist devices along with data management and support services.

Physio-Control also brings an enhanced presence and infrastructure that would expand Stryker's global footprint. The company's sales for fiscal 2015 totaled USD 503 million, up 6 percent in constant currency over the prior year.

The acquisition is expected to close at the beginning of the second quarter and be slightly accretive to the adjusted per share earnings in 2016. Revised adjusted 2016 EPS guidance reflecting the acquisition and the previously announced transactions is USD 5.57-5.77 up 8.8-12.7 percent, which includes a 2.5 percent negative foreign exchange rate impact on the adjusted earnings per share. For 2017, the acquisition of Sage and Physio-Control combined will be accretive by USD 0.15-0.18, net of the negative impact of postponing the share repurchases that were included in original guidance for 2016.

10 Diagnostic Imaging Trends for 2018



Digital version